What does ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' do?

''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is a specialist medical practice in Asse. Private Limited, started on 23 March 2011, 1 establishment.

What is the address of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

The registered office of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is located at Pameiblok 7, 1730 Asse.

Is ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' still active?

Yes. According to the CBE (30 September 2026) ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is active, legal situation “Normale toestand”, started on 23 March 2011.

Is ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' registered on Peppol?

Yes, ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is registered on the Peppol network with ID 0208:0834764281.

What is the enterprise number of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

The enterprise number of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is BE0834764281.

When was ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' founded?

''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' was founded on 23 March 2011.

Who are the directors of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

According to the 2025 annual accounts, the directors of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' are: Isabelle Vande Broek.

Is ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 March 2011; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' make in 2025?

''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' posted a profit after taxes of € 184,996 in financial year 2025.

What is the revenue of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

As a small company, ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 273,469.

''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' (Private Limited)

Dossier ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'', printed on 30 September 2026 from databakkes.be/en/0834764281/dr-isabelle-vande-broek-hematoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' from Asse, company number BE0834764281, closed financial year 2025 with a result of € 184,996 after tax. For that financial year ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' recorded a gross margin of € 273,469 and equity of € 712,153. Compared with financial year 2024, the result moved from € 153,884 to € 184,996. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 7, 2026.

What it is worth Healthy

€ 712,153

▼ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 184,996

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 209,322

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 460,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 9,234

▲ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 118,159

▼ 11% vs 2024

€ 15,571 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 2,332

▼ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 29,024

▲ 65% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 176,563 Gross margin 2022: € 176,563 First fiscal year in the series	€ 185,090 Gross margin 2023: € 185,090 ▲ 5% vs 2022 (€ 176,563) Favourable step	€ 223,633 Gross margin 2024: € 223,633 ▲ 21% vs 2023 (€ 185,090) Favourable step	€ 273,469 Gross margin 2025: € 273,469 ▲ 22% vs 2024 (€ 223,633) Favourable step	▲ 22%
Profit after taxes	€ 121,128 Profit after taxes 2022: € 121,128 First fiscal year in the series	€ 131,625 Profit after taxes 2023: € 131,625 ▲ 9% vs 2022 (€ 121,128) Favourable step	€ 153,884 Profit after taxes 2024: € 153,884 ▲ 17% vs 2023 (€ 131,625) Favourable step	€ 184,996 Profit after taxes 2025: € 184,996 ▲ 20% vs 2024 (€ 153,884) Favourable step	▲ 20%
Equity	€ 721,648 Equity 2022: € 721,648 First fiscal year in the series	€ 833,273 Equity 2023: € 833,273 ▲ 15% vs 2022 (€ 721,648) Favourable step	€ 987,157 Equity 2024: € 987,157 ▲ 18% vs 2023 (€ 833,273) Favourable step	€ 712,153 Equity 2025: € 712,153 ▼ 28% vs 2024 (€ 987,157) Unfavourable step	▼ 28%
Total debts	€ 179,543 Total debts 2022: € 179,543 First fiscal year in the series	€ 161,407 Total debts 2023: € 161,407 ▼ 10% vs 2022 (€ 179,543) Favourable step	€ 158,964 Total debts 2024: € 158,964 ▼ 2% vs 2023 (€ 161,407) Favourable step	€ 149,515 Total debts 2025: € 149,515 ▼ 6% vs 2024 (€ 158,964) Favourable step	▼ 6%
Cash	€ 37,741 Cash 2022: € 37,741 First fiscal year in the series	€ 51,096 Cash 2023: € 51,096 ▲ 35% vs 2022 (€ 37,741) Favourable step	€ 150,916 Cash 2024: € 150,916 ▲ 195% vs 2023 (€ 51,096) Favourable step	€ 209,322 Cash 2025: € 209,322 ▲ 39% vs 2024 (€ 150,916) Favourable step	▲ 39%
Land & buildings	€ 69,837 Land & buildings 2022: € 69,837 First fiscal year in the series	€ 61,132 Land & buildings 2023: € 61,132 ▼ 12% vs 2022 (€ 69,837) Unchanged	€ 52,648 Land & buildings 2024: € 52,648 ▼ 14% vs 2023 (€ 61,132) Unchanged	€ 44,163 Land & buildings 2025: € 44,163 ▼ 16% vs 2024 (€ 52,648) Unchanged	▼ 16%
Retained profit	€ 709,248 Retained profit 2022: € 709,248 First fiscal year in the series	€ 820,873 Retained profit 2023: € 820,873 ▲ 16% vs 2022 (€ 709,248) Favourable step	€ 974,757 Retained profit 2024: € 974,757 ▲ 19% vs 2023 (€ 820,873) Favourable step	€ 699,753 Retained profit 2025: € 699,753 ▼ 28% vs 2024 (€ 974,757) Unfavourable step	▼ 28%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 20,000) Unchanged	€ 460,000 Dividend 2025: € 460,000 Unchanged (€ 0) Unchanged
Bank debt	€ 160,926 Bank debt 2022: € 160,926 First fiscal year in the series	€ 147,299 Bank debt 2023: € 147,299 ▼ 8% vs 2022 (€ 160,926) Favourable step	€ 133,053 Bank debt 2024: € 133,053 ▼ 10% vs 2023 (€ 147,299) Favourable step	€ 118,159 Bank debt 2025: € 118,159 ▼ 11% vs 2024 (€ 133,053) Favourable step	▼ 11%
Balance sheet total	€ 901,191 Balance sheet total 2022: € 901,191 First fiscal year in the series	€ 994,680 Balance sheet total 2023: € 994,680 ▲ 10% vs 2022 (€ 901,191) Unchanged	€ 1,146,121 Balance sheet total 2024: € 1,146,121 ▲ 15% vs 2023 (€ 994,680) Unchanged	€ 861,668 Balance sheet total 2025: € 861,668 ▼ 25% vs 2024 (€ 1,146,121) Unchanged	▼ 25%

Key figures of ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'', fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

What happened at ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 7, 2026 New annual accounts for financial year 2025: profit of € 184,996 (▲ 20% vs 2024). Source: NBB ↗
Mar 23, 2011 Start of the company according to the CBE. KBO
Mar 15, 2011 New establishment in Asse. KBO
2011 Isabelle Vande Broek became a director. NBB

In short

From € 121,128 profit in 2022 to € 184,996 profit in 2025.

Paid € 268,989 in corporate taxes since 2022.

Best year ever: 2025, with € 184,996 profit.

Paid out € 480,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''? We notify you, reason included.

Follow ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle Vande Broek

''DR. ISABELLE VANDE BROEK, HEMATOLOOG''

Behind ''DR. ISABELLE VANDE BROEK, HEMATOLOOG'' is Isabelle Vande Broek.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle Vande Broek

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Pameiblok 7

1730 Asse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0834.764.281

VAT number

BE 0834.764.281

Registered office

Pameiblok 7, 1730 Asse

Names & denominations

''DR. ISABELLE VANDE BROEK, HEMATOLOOG''

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 March 2011

Peppol

Active · Active since 14 Jan 2026

Activities · NACE

Activiteiten van medisch specialisten

Overige onderwijsondersteunende dienstverlening

View on CBE Public ↗ Annual accounts (NBB) ↗

''DR. ISABELLE VANDE BROEK, HEMATOLOOG''

Financials

What happened to ''DR. ISABELLE VANDE BROEK, HEMATOLOOG''?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions